RLYB
Rallybio Corp
NASDAQ · Healthcare · Biotechnology · US
$15.90
+0.25%0
Insider buys (3m)
1
Insider sells (3m)
-$9.6K
Net value (3m)
-1.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Nov 3, 2026 | Lieber Jonathan I · officer: Chief Financial Officer | M-Exempt | 7,124 | $15 |
| Nov 2, 2026 | HUNT RONALD · director | M-Exempt | 2,062 | $15 |
| Nov 2, 2026 | HUNT RONALD · director | M-Exempt | 9,196 | $7.60 |
| Nov 2, 2026 | Lieber Jonathan I · officer: Chief Financial Officer | M-Exempt | 13,589 | $6.08 |
| Nov 2, 2026 | Lieber Jonathan I · officer: Chief Financial Officer | M-Exempt | 7,875 | $15 |
| Nov 2, 2026 | HUNT RONALD · director | M-Exempt | 3,562 | $2.38 |
| Oct 30, 2026 | Nash Christine A · director | M-Exempt | 3,562 | $2.38 |
| Oct 29, 2026 | Uden Stephen · director, officer: Chief Executive Officer | M-Exempt | 33,244 | $6.08 |
| Oct 28, 2026 | Lieber Jonathan I · officer: Chief Financial Officer | A-Award | 2,500 | $0.00 |
| Oct 28, 2026 | Lieber Jonathan I · officer: Chief Financial Officer | Sale | 599 | $16 |
| Oct 28, 2026 | Chung Wendy · director | M-Exempt | 2,062 | $15 |
| Oct 20, 2026 | Soteropoulos Paula · director | M-Exempt | 3,562 | $2.38 |
| Oct 20, 2026 | Boudreau Helen M · director | M-Exempt | 2,062 | $15 |
| Oct 14, 2026 | Hopfner Robert Lorne · director | M-Exempt | 9,196 | $7.60 |
| Oct 14, 2026 | Hopfner Robert Lorne · director | M-Exempt | 3,562 | $2.38 |
| Oct 14, 2026 | Hopfner Robert Lorne · director | M-Exempt | 2,062 | $15 |
| Oct 13, 2026 | Lieber Jonathan I · officer: Chief Financial Officer | M-Exempt | 3,910 | $6.08 |
| Oct 8, 2026 | Uden Stephen · director, officer: Chief Executive Officer | M-Exempt | 22,456 | $6.08 |
| Oct 1, 2026 | Lieber Jonathan I · officer: Chief Financial Officer | M-Exempt | 5,000 | $6.08 |
| Sep 28, 2026 | Liu Hui · director | M-Exempt | 8,482 | $7.60 |
| Sep 28, 2026 | Liu Hui · director | M-Exempt | 3,562 | $2.38 |
| Sep 18, 2026 | Chung Wendy · director | M-Exempt | 3,562 | $2.38 |
| Jul 10, 2026 | Boudreau Helen M · director | M-Exempt | 3,562 | $2.38 |
| May 20, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 10,000 | $14 |
| May 20, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 200 | $14 |
| May 20, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 6,009 | $14 |
| May 15, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 75,178 | $14 |
| May 15, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 200 | $14 |
| May 15, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 4,081 | $14 |
| May 15, 2026 | ADAR1 Capital Management, LLC · 10 percent owner | Purchase | 100 | $14 |
Institutional positioning
13F filings over the trailing two quarters
New 20Increased 11Reduced 29Sold out 12
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ADAR1 Capital Management, LLC | Increased | 926,352 | Aug 14, 2026 |
| FMR LLC | Increased | 794,720 | Aug 13, 2026 |
| FMR LLC | Reduced | 793,451 | May 15, 2026 |
| VIKING GLOBAL INVESTORS LP | Reduced | 524,347 | May 15, 2026 |
| VIKING GLOBAL INVESTORS LP | Unchanged | 524,347 | Aug 14, 2026 |
| CORMORANT ASSET MANAGEMENT, LP | New Position | 400,000 | May 15, 2026 |
| TPG GP A, LLC | Reduced | 378,551 | May 15, 2026 |
| TPG GP A, LLC | Unchanged | 378,551 | Aug 14, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | New Position | 376,573 | May 15, 2026 |
| LAURION CAPITAL MANAGEMENT LP | New Position | 302,756 | May 14, 2026 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | New Position | 300,635 | May 15, 2026 |
| Pivotal bioVenture Partners Investment Advisor LLC | Unchanged | 300,579 | Aug 13, 2026 |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | Reduced | 300,579 | May 14, 2026 |
| 5AM VENTURE MANAGEMENT, LLC | Reduced | 291,788 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 199,907 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Nov 3, 2026